Literature DB >> 32623494

A comparative study of microbial community and functions of type 2 diabetes mellitus patients with obesity and healthy people.

Ting-Ye Wang1, Xin-Qing Zhang2, Ai-Ling Chen2, Jing Zhang3,4, Bo-Han Lv1, Meng-Hua Ma3, Juan Lian1, Yan-Xiang Wu1, Yun-Tao Zhou3, Cong-Cong Ma2, Rui-Juan Dong1, Dong-Yu Ge1, Si-Hua Gao5,6, Guang-Jian Jiang7,8.   

Abstract

The gut microbiota is crucial in the pathogenesis of type 2 diabetes mellitus (T2DM). However, the metabolism of T2DM patients is not well-understood. We aimed to identify the differences on composition and function of gut microbiota between T2DM patients with obesity and healthy people. In this study, 6 T2DM patients with obesity and 6 healthy volunteers were recruited, and metagenomic approach and bioinformatics analysis methods were used to understand the composition of the gut microbiota and the metabolic network. We found a decrease in the abundance of Firmicutes, Oribacterium, and Paenibacillus; this may be attributed to a possible mechanism and biological basis of T2DM; moreover, we identified three critical bacterial taxa, Bacteroides plebeius, Phascolarctobacterium sp. CAG207, and the order Acidaminococcales that can potentially be used for T2DM treatment. We also revealed the composition of the microbiota through functional annotation based on multiple databases and found that carbohydrate metabolism contributed greatly to the pathogenesis of T2DM. This study helps in elucidating the different metabolic roles of microbes in T2DM patients with obesity.

Entities:  

Keywords:  Metagenome; Microbiome; Obesity; Type 2 diabetes

Mesh:

Year:  2020        PMID: 32623494     DOI: 10.1007/s00253-020-10689-7

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  11 in total

1.  The role of the gut microbiota on the metabolic status of obese children.

Authors:  Xin Yuan; Ruimin Chen; Kenneth L McCormick; Ying Zhang; Xiangquan Lin; Xiaohong Yang
Journal:  Microb Cell Fact       Date:  2021-02-27       Impact factor: 5.328

2.  Characteristics and variation of fecal bacterial communities and functions in isolated systolic and diastolic hypertensive patients.

Authors:  Pan Wang; Ying Dong; Kun Zuo; Chunming Han; Jie Jiao; Xinchun Yang; Jing Li
Journal:  BMC Microbiol       Date:  2021-04-26       Impact factor: 3.605

3.  Gut Microbiota of Chinese Obese Children and Adolescents With and Without Insulin Resistance.

Authors:  Xin Yuan; Ruimin Chen; Ying Zhang; Xiangquan Lin; Xiaohong Yang; Kenneth L McCormick
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-19       Impact factor: 5.555

4.  Characterization of fructooligosaccharide metabolism and fructooligosaccharide-degrading enzymes in human commensal butyrate producers.

Authors:  Hiroki Tanno; Tadashi Fujii; Katsuaki Hirano; Shintaro Maeno; Takashi Tonozuka; Mitsuo Sakamoto; Moriya Ohkuma; Takumi Tochio; Akihito Endo
Journal:  Gut Microbes       Date:  2021 Jan-Dec

5.  Gut Microbiome Alterations in Patients With Visceral Obesity Based on Quantitative Computed Tomography.

Authors:  Hang Yan; Qian Qin; Jengfeng Chen; Su Yan; Tiantian Li; Xinxin Gao; Yang Yang; Ang Li; Suying Ding
Journal:  Front Cell Infect Microbiol       Date:  2022-01-20       Impact factor: 5.293

Review 6.  Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.

Authors:  Zheng Zhou; Bao Sun; Dongsheng Yu; Chunsheng Zhu
Journal:  Front Cell Infect Microbiol       Date:  2022-02-15       Impact factor: 5.293

7.  Effects of Short-Chain Fatty Acid Modulation on Potentially Diarrhea-Causing Pathogens in Yaks Through Metagenomic Sequencing.

Authors:  Kun Li; Zhibo Zeng; Juanjuan Liu; Lulu Pei; Yaping Wang; Aoyun Li; Muhammad Fakhar-E-Alam Kulyar; Muhammad Shahzad; Khalid Mehmood; Jiakui Li; Desheng Qi
Journal:  Front Cell Infect Microbiol       Date:  2022-03-23       Impact factor: 5.293

8.  The Effect of Short-Term Consumption of Lactic Acid Bacteria on the Gut Microbiota in Obese People.

Authors:  Inna Burakova; Yuliya Smirnova; Mariya Gryaznova; Mikhail Syromyatnikov; Pavel Chizhkov; Evgeny Popov; Vasily Popov
Journal:  Nutrients       Date:  2022-08-18       Impact factor: 6.706

9.  Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial.

Authors:  Valentin Mocanu; Zhengxiao Zhang; Edward C Deehan; Dina H Kao; Naomi Hotte; Shahzeer Karmali; Daniel W Birch; Kalutota K Samarasinghe; Jens Walter; Karen L Madsen
Journal:  Nat Med       Date:  2021-07-05       Impact factor: 53.440

Review 10.  Molecular Mechanism of Puerarin Against Diabetes and its Complications.

Authors:  Yi-Ling Bai; Ling-Ling Han; Jun-Hui Qian; Hao-Zhong Wang
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.